OMLIVULT Trademark

Trademark Overview

On Friday, May 3, 2019, a trademark application was filed for OMLIVULT with the United States Patent and Trademark Office. The USPTO has given the OMLIVULT trademark a serial number of 88414211. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 17, 2022. This trademark is owned by Amgen Inc.. The OMLIVULT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in the treatment of cancer, tumorous diseases, autoimmune diseases, inflammation, inflammatory diseases and disorders, neurologic diseases and disorders, metabolic diseases and disorders, and cardiovascular diseases and disorders
omlivult

General Information

Serial Number88414211
Word MarkOMLIVULT
Filing DateFriday, May 3, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 17, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 16, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations for use in the treatment of cancer, tumorous diseases, autoimmune diseases, inflammation, inflammatory diseases and disorders, neurologic diseases and disorders, metabolic diseases and disorders, and cardiovascular diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, May 19, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAmgen Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201799
Party NameAmgen Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201799

Trademark Events

Event DateEvent Description
Monday, October 17, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, October 17, 2022ABANDONMENT - NO USE STATEMENT FILED
Thursday, February 24, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 23, 2022SOU EXTENSION 5 GRANTED
Wednesday, February 16, 2022SOU EXTENSION 5 FILED
Wednesday, February 16, 2022SOU TEAS EXTENSION RECEIVED
Saturday, August 14, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, August 12, 2021SOU EXTENSION 4 GRANTED
Thursday, August 12, 2021SOU EXTENSION 4 FILED
Thursday, August 12, 2021SOU TEAS EXTENSION RECEIVED
Thursday, April 22, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 21, 2021SOU EXTENSION 3 GRANTED
Wednesday, March 10, 2021SOU EXTENSION 3 FILED
Tuesday, April 20, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, March 17, 2021NOTICE OF REVIVAL - E-MAILED
Tuesday, March 16, 2021SOU EXTENSION RECEIVED WITH TEAS PETITION
Tuesday, March 16, 2021PETITION TO REVIVE-GRANTED
Tuesday, March 16, 2021TEAS PETITION TO REVIVE RECEIVED
Wednesday, September 2, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 31, 2020SOU EXTENSION 2 GRANTED
Monday, August 31, 2020SOU EXTENSION 2 FILED
Monday, August 31, 2020SOU TEAS EXTENSION RECEIVED
Saturday, February 29, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 27, 2020SOU EXTENSION 1 GRANTED
Thursday, February 27, 2020SOU EXTENSION 1 FILED
Thursday, February 27, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, September 10, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 16, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 16, 2019PUBLISHED FOR OPPOSITION
Wednesday, June 26, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, June 7, 2019ASSIGNED TO LIE
Friday, May 24, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, May 24, 2019EXAMINER'S AMENDMENT ENTERED
Friday, May 24, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, May 24, 2019EXAMINERS AMENDMENT E-MAILED
Friday, May 24, 2019EXAMINERS AMENDMENT -WRITTEN
Wednesday, May 22, 2019ASSIGNED TO EXAMINER
Sunday, May 19, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, May 7, 2019NEW APPLICATION ENTERED

Related Keywords

omlivult diseases disorders inflammatory neurologic cardiovascular metabolic inflammation autoimmune preparations treatment